Page last updated: 2024-08-21

4-hydroxybutyric acid and Substance Withdrawal Syndrome

4-hydroxybutyric acid has been researched along with Substance Withdrawal Syndrome in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.70)18.2507
2000's13 (48.15)29.6817
2010's7 (25.93)24.3611
2020's6 (22.22)2.80

Authors

AuthorsStudies
Brunetti, P; Umani Ronchi, F1
Ebdrup, BH; Kjærgaard, MF; Nørbæk, JJ; Videbech, P1
Bae, JW; Choi, B; Ji, M; Kim, M; Kim, S; Lee, S; Lee, YS; Oh, S; Paik, MJ1
Kestens, C; Moitroux, A1
Dijkstra, B; van Mechelen, JC; Vergouwen, A1
Beurmanjer, H; Buwalda, VJA; De Jong, CAJ; De Wilde, B; Dijkstra, BAG; Luykx, JJ; Schellekens, AFA; van Rompaey, K1
Amsterdam, JV; Brink, WVD; Brunt, TM; Crunelle, CL; Pereira, FR1
Broers, B; de Jong, CA; Kamal, R; van Noorden, M1
de Jong, CA; Dijkstra, BA; Kamal, RM; van Iwaarden, S1
Boettger, S; Claussen, MC; Hassanpour, K; Jenewein, J1
Greene, S; Kailainathan, R; Koutsogiannis, Z; Wong, A1
Elsing, C; Grenda, U; Herrmann, T; Stremmel, W1
Bernardi, M; Caputo, F; Maremmani, I; Vignoli, T; Zoli, G1
Amato, L; Davoli, M; Minozzi, S1
Dell'Osso, L; Maremmani, AG; Maremmani, I; Pacini, M; Pani, PP; Rovai, L1
Biggio, F; Biggio, G; Busonero, F; Follesa, P; Manca, A; Mancuso, L; Mascia, MP; Mostallino, MC; Sanna, E; Talani, G1
Atzeri, S; Carai, MA; Colombo, G; Gessa, GL; Lobina, C; Maccioni, P; Maher, TJ; Orrù, A; Quang, LS1
Gibson, KM; Snead, OC1
Gortner, L; Gottschling, S; Kleinschmidt, S; Meyer, S; Strittmatter, M1
Addolorato, G; Gasbarrini, G1
Carai, MA; Colombo, G; Gessa, GL; Lobina, C; Maccioni, P; Maher, TJ; Orru, A; Quang, LS1
Bernardi, M; Caputo, F; Francini, S; Stoppo, M; Vignoli, T1
Bennett, WR; Roy-Byrne, PP; Wilson, LG1
Addolorato, G; Attilia, ML; Balducci, G; Capristo, E; Ceccanti, M; Gasbarrini, G; Taggi, F1
Gallimberti, L; Gessa, GL; Soncini, CA; Spella, MR1
Contini, SE; Frederick-Osborne, SL; Galloway, GP; Seymour, R; Smith, DE1
Agabio, R; Carai, MA; Colombo, G; Gessa, GL; Lobina, C; Pani, M; Reali, R1

Reviews

8 review(s) available for 4-hydroxybutyric acid and Substance Withdrawal Syndrome

ArticleYear
Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.
    Current neuropharmacology, 2022, Volume: 20, Issue:4

    Topics: Alcoholism; Animals; Cognitive Dysfunction; Coma; Humans; Hydroxybutyrates; Illicit Drugs; Neurotoxicity Syndromes; Sodium Oxybate; Substance Withdrawal Syndrome

2022
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
    International journal of environmental research and public health, 2009, Volume: 6, Issue:6

    Topics: Alcoholism; Humans; Hydroxybutyrates; Motivation; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome

2009
Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome.
    The Cochrane database of systematic reviews, 2011, Jun-15, Issue:6

    Topics: Alcohol Withdrawal Seizures; Alcoholism; Anticonvulsants; Baclofen; Benzodiazepines; Ethanol; Humans; Hydroxybutyrates; Nitrous Oxide; Substance Withdrawal Syndrome

2011
Gamma-hydroxybutyric acid.
    The New England journal of medicine, 2005, Jun-30, Volume: 352, Issue:26

    Topics: 4-Butyrolactone; Animals; Butylene Glycols; Humans; Hydroxybutyrates; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders

2005
[Gamma-hydroxy butyric acid: neurotransmitter, sedative and party drug].
    Wiener medizinische Wochenschrift (1946), 2005, Volume: 155, Issue:13-14

    Topics: Adult; Animals; Brain; Child; Critical Care; Drug Overdose; gamma-Aminobutyric Acid; Humans; Hydroxybutyrates; Hypnotics and Sedatives; Illicit Drugs; Neurotransmitter Agents; Substance Withdrawal Syndrome

2005
Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence.
    Alcohol (Fayetteville, N.Y.), 2000, Volume: 20, Issue:3

    Topics: Alcoholism; Clinical Trials as Topic; Heroin Dependence; Humans; Hydroxybutyrates; Substance Withdrawal Syndrome; Substance-Related Disorders

2000
Abuse and therapeutic potential of gamma-hydroxybutyric acid.
    Alcohol (Fayetteville, N.Y.), 2000, Volume: 20, Issue:3

    Topics: Alcoholism; Animals; Brain; Humans; Hydroxybutyrates; Substance Withdrawal Syndrome; Substance-Related Disorders

2000
Mechanism of the antialcohol effect of gamma-hydroxybutyric acid.
    Alcohol (Fayetteville, N.Y.), 2000, Volume: 20, Issue:3

    Topics: Alcohol Drinking; Alcoholism; Animals; Dopamine; Ethanol; Humans; Hydroxybutyrates; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders

2000

Trials

2 trial(s) available for 4-hydroxybutyric acid and Substance Withdrawal Syndrome

ArticleYear
Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
    The American journal of drug and alcohol abuse, 2009, Volume: 35, Issue:3

    Topics: Adult; Alcoholism; Chlormethiazole; Comorbidity; Female; GABA Modulators; Humans; Hydroxybutyrates; Intensive Care Units; Length of Stay; Male; Middle Aged; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome

2009
Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Alcoholism, clinical and experimental research, 1999, Volume: 23, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Central Nervous System Depressants; Depression; Ethanol; Female; Humans; Hydroxybutyrates; Male; Middle Aged; Substance Withdrawal Syndrome; Surveys and Questionnaires

1999

Other Studies

17 other study(ies) available for 4-hydroxybutyric acid and Substance Withdrawal Syndrome

ArticleYear
Recreational use of GHB and prescribed drugs: the challenge in forensic and clinical toxicology.
    La Clinica terapeutica, 2021, Sep-29, Volume: 172, Issue:5

    Topics: Humans; Hydroxybutyrates; Illicit Drugs; Sodium Oxybate; Substance Withdrawal Syndrome

2021
Gamma-hydroxybutyric acid-induced organic delirium complicated by polydrug use successfully treated with electroconvulsive therapy: a case report.
    Journal of medical case reports, 2021, Dec-16, Volume: 15, Issue:1

    Topics: Adult; Delirium; Electroconvulsive Therapy; Humans; Hydroxybutyrates; Male; Substance Withdrawal Syndrome; Young Adult

2021
Alcohol perturbed locomotor behavior, metabolism, and pharmacokinetics of gamma-hydroxybutyric acid in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 164

    Topics: Alcoholism; Animals; Ethanol; gamma-Aminobutyric Acid; Rats; Sodium Oxybate; Substance Withdrawal Syndrome

2023
[Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
    Revue medicale de Liege, 2023, Volume: 78, Issue:7-8

    Topics: Benzodiazepines; Humans; Hydroxybutyrates; Sodium Oxybate; Substance Withdrawal Syndrome

2023
Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
    BMJ case reports, 2019, Dec-02, Volume: 12, Issue:12

    Topics: Adult; Female; Humans; Hydroxybutyrates; Illicit Drugs; Pregnancy; Pregnancy Complications; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders

2019
Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.
    CNS drugs, 2020, Volume: 34, Issue:6

    Topics: Adult; Belgium; Benzodiazepines; Craving; Drug Tapering; Female; Humans; Hydroxybutyrates; Male; Netherlands; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult

2020
Treatment of GHB withdrawal syndrome: Catch 22 or challenge for addiction medicine?
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:9

    Topics: Humans; Hydroxybutyrates; Practice Guidelines as Topic; Substance Withdrawal Syndrome

2013
Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
    Drug and alcohol dependence, 2014, Feb-01, Volume: 135

    Topics: Adult; Behavior, Addictive; Cohort Studies; Decision Making; Female; Humans; Hydroxybutyrates; Male; Prospective Studies; Psychiatry; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult

2014
Catatonic stupor secondary to gamma-hydroxy-butyric acid (GHB)-dependence and -withdrawal syndrome.
    Psychiatria Danubina, 2014, Volume: 26, Issue:4

    Topics: Catatonia; Humans; Hydroxybutyrates; Male; Middle Aged; Stupor; Substance Withdrawal Syndrome; Substance-Related Disorders

2014
Recognition of gamma-hydroxybutyric acid withdrawal: Rapid progression and prolonged symptomatology.
    Emergency medicine Australasia : EMA, 2017, Volume: 29, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Australia; Baclofen; Benzodiazepines; Diazepam; Humans; Hydroxybutyrates; Male; Penicillanic Acid; Phenobarbital; Piperacillin; Pneumonia; Psychomotor Agitation; Substance Withdrawal Syndrome; Sweating; Tazobactam; Tremor

2017
Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.
    International journal of environmental research and public health, 2011, Volume: 8, Issue:7

    Topics: Adult; Alcohol Deterrents; Alcoholics; Alcoholism; Disulfiram; Drug Therapy, Combination; Ethanol; Female; Humans; Hydroxybutyrates; Italy; Male; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome

2011
Gamma-hydroxybutyric acid and diazepam antagonize a rapid increase in GABA(A) receptors alpha(4) subunit mRNA abundance induced by ethanol withdrawal in cerebellar granule cells.
    Molecular pharmacology, 2003, Volume: 63, Issue:4

    Topics: Animals; Cells, Cultured; Cerebellum; Diazepam; Drug Interactions; Electrophysiology; Ethanol; Humans; Hydroxybutyrates; Neurons; Protein Subunits; Rats; Receptors, GABA-A; RNA, Messenger; Substance Withdrawal Syndrome; Transfection; Xenopus laevis

2003
Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Brain research. Brain research protocols, 2005, Volume: 15, Issue:2

    Topics: Animals; Butylene Glycols; Disease Models, Animal; GABA-B Receptor Antagonists; Hydroxybutyrates; Male; Morpholines; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders

2005
Gamma-hydroxybutyric acid.
    The New England journal of medicine, 2005, Oct-13, Volume: 353, Issue:15

    Topics: Alcoholism; Humans; Hydroxybutyrates; Substance Withdrawal Syndrome

2005
Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Annals of the New York Academy of Sciences, 2006, Volume: 1074

    Topics: 4-Butyrolactone; Animals; Behavior, Animal; Butylene Glycols; Female; Hydroxybutyrates; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Rats, Wistar; Seizures; Substance Withdrawal Syndrome

2006
GABAergic medications for treating alcohol dependence.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5

    Topics: Alcoholism; Baclofen; Drug Therapy, Combination; GABA Agonists; gamma-Aminobutyric Acid; Humans; Hydroxybutyrates; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Receptors, GABA-B; Substance Withdrawal Syndrome; Temperance

2007
Gamma-hydroxybutyric acid (GHB) withdrawal: a case report.
    Journal of psychoactive drugs, 2007, Volume: 39, Issue:3

    Topics: Adjuvants, Anesthesia; Adult; Antipsychotic Agents; Benzodiazepines; Humans; Hydroxybutyrates; Male; Olanzapine; Substance Withdrawal Syndrome; Treatment Failure

2007